FRE — Firebrick Pharma Share News
0.000.00%
Last trade - 00:00- AU$8.56m
- AU$7.23m
- AU$0.11m
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement
Brief: Firebrick Pharma Agrees And Approves Of Nasodine In Indonesia
Brief: Firebrick Pharma Requests Trading Halt Pending Placement Announcement
Australia's Firebrick Pharma gains on patent acceptance in the Philippines
Australia's Firebrick Pharma jumps on manufacturing new product for export
Brief: Firebrick Pharma Announces License Agreement For Singapore, Malaysia, Brunei, Mauritius
Brief: Firebrick Pharma Secures A$1.4 Million From Investors
Brief: Firebrick Pharma Says Nasodine Covid-19 Patent Granted In Australia
Brief: Firebrick Pharma Says Nasodine COVID-19 Patent Accepted In Europe
Brief: Firebrick Pharma Seeks Trading Halt
Brief: Firebrick Pharma Seeks Trading Halt
Brief: Firebrick Pharma Secures Strategic Investment From Philippines Partner
Australia's Firebrick Pharma hits over 10-month high on securing investment
Brief: Firebrick Pharma Says Seeks Trading Halt Pending Announcement Regarding A Share Placement
Brief: Firebrick Pharma Executes License And Distribution Agreement For Nasodine Nasal Spray
Brief: Firebrick Pharma Says Nasodine Covid-19 Patent Allowed In Mexico